Anthony Hunt, Director at REPLIGEN CORP (RGEN), sold 35,400 shares at $151.01 ($5.5M) on 2025-11-13, disclosed to the SEC on 2025-11-14.
Seasonal sale ($5.5M) by Director — this insider has traded RGEN in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $151.01 | 1,784 | $269K | 4.9% |
| 2 | $151.01 | 1,784 | $269K | 4.9% |
| 3 | $152.17 | 2,100 | $320K | 5.8% |
| 4 | $153.14 | 2,923 | $448K | 8.2% |
| 5 | $153.14 | 2,923 | $448K | 8.2% |
| 6 | $154.32 | 2,500 |
| $386K |
| 7.0% |
| 7 | $155.45 | 3,000 | $466K | 8.5% |
| 8 | $155.45 | 3,000 | $466K | 8.5% |
| 9 | $156.22 | 5,737 | $896K | 16.4% |
| 10 | $156.22 | 5,737 | $896K | 16.4% |
| 11 | $157.11 | 1,956 | $307K | 5.6% |
| 12 | $157.11 | 1,956 | $307K | 5.6% |
| Total | $154.78 avg | 35,400 | $5.5M | 100% |
| Filing → |
| RGEN | SELL | 2025-05-16 | $6.5M | — | Filing → |
| RGEN | SELL | 2025-03-19 | $8.1M | — | Filing → |
| RGEN | SELL | 2024-11-22 | $6.8M | — | Filing → |